Significant Recognition for REMaST® Therapy, a New Perspective for Medullo-Injured Patients
Hemera has been chosen among the most innovative scientific entrepreneurial initiatives in Italy by the investment holding company Scientific Venture Capital. This firm specializes in accelerating high-tech startups capable of generating a positive social impact.
This is a meaningful acknowledgment of the contribution our REMaST® therapy can make to patients with spinal cord injuries. It marks a crucial step that opens new perspectives of hope and independence for those facing this challenge.